Autologous T-cell receptor (TCR) therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Autologous T-cell receptor (TCR) therapy, covering 2025-11-10 to 2025-11-10. Get the full timeline:
Most recent: Clinical Trial Update: Phase I/II Study of Autologous T Cells to Express T-Cell Receptors (TCRs) in Subjects With Solid Tumors [Phase 1, Phase 2]